Literature DB >> 34101789

The Epidemiology of Alzheimer's Disease Modifiable Risk Factors and Prevention.

X-X Zhang1, Y Tian, Z-T Wang, Y-H Ma, L Tan, J-T Yu.   

Abstract

Mild Alzheimer's disease is the leading cause of dementia, accounting for 50-70% of cases. Alzheimer's disease is an irreversible neurodegenerative disease, which affects daily life activities and social functioning. As life expectancy increases and demographic ageing occurs, the global prevalence of Alzheimer's disease is expected to continue to rise especially in developing countries, leading to a costly burden of disease. Alzheimer's disease is a complex and multifactorial disorder that is determined by the interaction of genetic susceptibility and environmental factors across the life course. Epidemiological studies have identified potential modifiable risk and protective factors for Alzheimer's disease prevention. Moreover, Alzheimer's disease is considered to start decades earlier before clinical symptoms occur, thus interventions targeting several risk factors in non-demented elderly people even middle-aged population might prevent or delay Alzheimer's disease onset. Here, we provide an overview of current epidemiological advances related to Alzheimer's disease modifiable risk factors, highlighting the concept of early prevention.

Entities:  

Keywords:  Alzheimer’s disease; epidemiology; modifiable risk factors; prevention

Year:  2021        PMID: 34101789     DOI: 10.14283/jpad.2021.15

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  27 in total

Review 1.  New insights into the role of fibroblast growth factors in Alzheimer's disease.

Authors:  Ramy Alam; Yara Mrad; Hussein Hammoud; Zahraa Saker; Youssef Fares; Elias Estephan; Hisham F Bahmad; Hayat Harati; Sanaa Nabha
Journal:  Mol Biol Rep       Date:  2021-11-03       Impact factor: 2.316

Review 2.  Implication of Paraprobiotics in Age-Associated Gut Dysbiosis and Neurodegenerative Diseases.

Authors:  Ziaur Rahman; Manoj P Dandekar
Journal:  Neuromolecular Med       Date:  2022-07-25       Impact factor: 4.103

3.  Dynamic functional connectivity patterns associated with dementia risk.

Authors:  Julie Gonneaud; Brigitte Landeau; Sophie Dautricourt; Vince D Calhoun; Robin de Flores; Géraldine Poisnel; Salma Bougacha; Valentin Ourry; Edelweiss Touron; Elizabeth Kuhn; Harriet Demintz-King; Natalie L Marchant; Denis Vivien; Vincent de la Sayette; Antoine Lutz; Gaël Chételat
Journal:  Alzheimers Res Ther       Date:  2022-05-23       Impact factor: 8.823

Review 4.  Hibiscus, Rooibos, and Yerba Mate for Healthy Aging: A Review on the Attenuation of In Vitro and In Vivo Markers Related to Oxidative Stress, Glycoxidation, and Neurodegeneration.

Authors:  Matheus Thomaz Nogueira Silva Lima; Eric Boulanger; Frédéric J Tessier; Jacqueline Aparecida Takahashi
Journal:  Foods       Date:  2022-06-07

Review 5.  Reassessment of Pioglitazone for Alzheimer's Disease.

Authors:  Ann M Saunders; Daniel K Burns; William Kirby Gottschalk
Journal:  Front Neurosci       Date:  2021-06-16       Impact factor: 4.677

Review 6.  Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.

Authors:  Teng Wan; Mingyuan Fu; Yan Jiang; Weiwei Jiang; Peiling Li; Shouhong Zhou
Journal:  Neurochem Res       Date:  2021-09-13       Impact factor: 3.996

7.  Association of Premenopausal Bilateral Oophorectomy With Cognitive Performance and Risk of Mild Cognitive Impairment.

Authors:  Walter A Rocca; Christine M Lohse; Carin Y Smith; Julie A Fields; Mary M Machulda; Michelle M Mielke
Journal:  JAMA Netw Open       Date:  2021-11-01

Review 8.  Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer's disease.

Authors:  Heba M Mansour; Hala M Fawzy; Aiman S El-Khatib; Mahmoud M Khattab
Journal:  Neural Regen Res       Date:  2022-09       Impact factor: 5.135

Review 9.  A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases.

Authors:  Sarmistha Saha; Brigitta Buttari; Elisabetta Profumo; Paolo Tucci; Luciano Saso
Journal:  Front Cell Neurosci       Date:  2022-01-21       Impact factor: 5.505

Review 10.  Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes?

Authors:  Erica Staurenghi; Serena Giannelli; Gabriella Testa; Barbara Sottero; Gabriella Leonarduzzi; Paola Gamba
Journal:  Antioxidants (Basel)       Date:  2021-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.